Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus. AJPS. 2026;26(3):302-315. doi:10.32947/ajps.v26i3.1420